000 01257nam a2200313Ia 4500
001 78624
003 BIBL
005 20160527202318.0
008 731001s1967 pau b s000 0 eng
010 _a 67026218
035 _a(OCoLC)00706133
040 _aDLC
_cAKR
_dm.c.
_dOCL
049 _aBDCG
050 0 _aKF;2036.D7
_bF55
082 _a658.8/09/6151
096 _aQV832.AA1
_bF613m 1967
100 1 0 _aFletcher, F Marion.
_wcn
_9224234
_2Local
245 1 0 _aMarket restraints in the retail drug industry
_c[by] F. Marion Fletcher.
260 0 _aPhiladelphia
_bUniversity of Pennsylvania Press
_c1967.
300 _axvi, 444 p.
_c24 cm.
490 1 _aIndustrial Research Unit study no. 43
500 _aRevision of thesis, University of Pennsylvania.
504 _aBibliography: p. [425]-433.
650 0 _aPharmacy
_xLaw and legislation
_zUnited States.
_wcm
_9150493
_2Local
650 2 _aLegislation, Drug
_zUnited States.
_9124571
_2Local
650 0 _aDrugs
_xPrices and sale.
_988821
_2Local
810 2 _aWharton School.
_bIndustrial Research Unit
_tIndustrial Research Unit study
_vno.43
_wcn
871 1 9 _j810/1
_aPennsylvania.
_bUniversity.
_bWharton School of Finance and Commerce.
_bIndustrial Research Unit.
_tIndustrial Research Unit study
_vno.43
999 _c63088
_d63088